Revenue | ₹1,160.24Cr |
Net Profits | ₹87.95Cr |
Net Profit Margins | 7.58% |
Strides Pharma Science Ltd’s revenue jumped 7.89% since last year same period to ₹1,160.24Cr in the Q3 2024-2025. On a quarterly growth basis, Strides Pharma Science Ltd has generated -2.94% fall in its revenue since last 3-months.
Strides Pharma Science Ltd’s net profit jumped 77.07% since last year same period to ₹87.95Cr in the Q3 2024-2025. On a quarterly growth basis, Strides Pharma Science Ltd has generated 22.42% jump in its net profits since last 3-months.
Strides Pharma Science Ltd’s net profit margin jumped 64.11% since last year same period to 7.58% in the Q3 2024-2025. On a quarterly growth basis, Strides Pharma Science Ltd has generated 26.13% jump in its net profit margins since last 3-months.
The revenue for Strides Pharma Science Ltd in the Q3 results 2024 was ₹1,160.24Cr.
The net profit for Strides Pharma Science Ltd in the Q3 results 2024 was ₹87.95Cr.
The net profit margin for Strides Pharma Science Ltd in the Q3 results 2024 was 7.58%.
The revenue for Strides Pharma Science Ltd in the Q3 results 2023 was ₹1,075.36Cr.
The net profit for Strides Pharma Science Ltd in the Q3 results 2023 was ₹49.67Cr.
The net profit margin for Strides Pharma Science Ltd in the Q3 results 2023 was 4.62%.